This site is intended for Healthcare Professionals only.

Tag: Merck; Ridgeback Biotherapeutics; molnupiravir; Covid-19

spot_imgspot_img

Merck begins late-stage trial of experimental Covid-19 drug

Merck and partner Ridgeback Biotherapeutics said on Wednesday (Sep 1) they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir...